Fujifilm Diosynth Biotechnologies (FDB) broke ground to signal the start of its expansion project on its North Carolina facility for cell culture and microbial capacity. The 31,778-sq-ft addition will increase cell culture manufacturing by approx. 25% and microbial capacity by approx. 50% through the installation of new recovery and purification suites. according to company officials. The $35m expansion project will include the addition of cell culture and high throughput manufacturing suites. The expanded facility will house multiple 500L and 2000L bioreactors to support the production of gene therapy products that have high production demands. Source: Genetic Engineering news 3/3/2020